<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="5639">
  <stage>Registered</stage>
  <submitdate>19/09/2012</submitdate>
  <approvaldate>19/09/2012</approvaldate>
  <nctid>NCT01716936</nctid>
  <trial_identification>
    <studytitle>A Retrospective Review of Early Onset Spinal Deformity Patients Treated With the Ellipse MAGEC System</studytitle>
    <scientifictitle>A Retrospective Multicenter Review of Early Onset Spinal Deformity Patients That Underwent Either a Primary or Revision Spinal Bracing Procedure With the Ellipse Technologies MAGEC Spinal Bracing and Distraction System</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>PR0056</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Thoracic Insufficiency Syndrome</healthcondition>
    <conditioncode>
      <conditioncode1>Human Genetics and Inherited Disorders</conditioncode1>
      <conditioncode2>Other human genetics and inherited disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Fetal medicine and complications of pregnancy</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>MAGEC Implant - All patients implanted with the MAGEC System will be reviewed for inclusion into this retrospective study.

</interventions>
    <comparator />
    <control />
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Change in Cobb Angle - Measured in Degrees</outcome>
      <timepoint>Baseline and 6, 12, 18 and 24 Months Postoperatively</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Change in Thoracic Spine Height - Measured in millimeters (mm)</outcome>
      <timepoint>Baseline and 6, 12, 18 and 24 Months Postoperatively</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Change in Space Available for Lung - Measured as a percentage (%)</outcome>
      <timepoint>Baseline and 6, 12, 18 and 24 Months Postoperatively</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Ocurrence of Procedure-Related Complications</outcome>
      <timepoint>Baseline, Device Implant and 6, 12, 18 and 24 Months Postoperatively</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Occurrence of Adverse Events</outcome>
      <timepoint>Baseline and 6, 12, 18 and 24 Months Postoperatively</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Change in Coronal Balance - Measured in millimeters (mm)</outcome>
      <timepoint>Baseline and 6, 12, 18 and 24 Months Postoperatively</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Change in Sagittal Balance - Measured in millimeters (mm)</outcome>
      <timepoint>Baseline and 6, 12, 18 and 24 Months Postoperatively</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Occurrence of Subsequent surgical interventions following initial implantation</outcome>
      <timepoint>Baseline and 6, 12, 18 and 24 Months Postoperatively</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Change in Weight - Measured in kilograms (kg)</outcome>
      <timepoint>Baseline and 6, 12, 18 and 24 Months Postoperatively</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Early onset spinal deformity with any etiology

          -  Cobb angle measurement of 30 degrees or greater at the time of primary surgery

          -  Thoracic spine height (T1 to T12) less than 22 cm at the time of primary surgery

          -  Age less than 11 years old at the time of MAGEC implant

          -  Implanted with the MAGEC system as either a primary or secondary revision spinal
             bracing procedure

          -  Patient has been implanted for a minimum of 6 months

          -  Patient signs informed consent for the use of their personal private data</inclusivecriteria>
    <inclusiveminage />
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage>11</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Patient declines to sign informed consent for the use of their personal private data.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing>Retrospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/07/2012</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>54</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/01/2013</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Egypt</country>
      <state>Cairo</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Finland</country>
      <state>Helsinki</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Finland</country>
      <state>Turku</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Hong Kong</country>
      <state>Hong Kong</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state>Bologna</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state>Rome</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Auckland</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Turkey</country>
      <state>Ankara</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Turkey</country>
      <state>Istanbul</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Turkey</country>
      <state>Izmir</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Middlesex</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Cardiff</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>London</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Ellipse Technologies, Inc.</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this study is to determine the safety profile and probable benefit of the
      Ellipse Technologies Inc. MAGEC System in subjects with early onset spinal deformity
      associated with thoracic insufficiency syndrome.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT01716936</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Behrooz A Akbarnia, MD</name>
      <address>San Diego Center for Spinal Disorders</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>